Finding new drugs to fight tuberculosis
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
This study is looking for new ways to fight tuberculosis by finding drugs that can block a key enzyme in the bacteria that causes the disease, especially to help people who have drug-resistant TB.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10876439 on NIH RePORTER |
What this research studies
This research focuses on discovering new inhibitors for a specific enzyme called 4'-phosphopantetheinyl transferase (PptT) that is crucial for the survival of Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB). By targeting this enzyme, the research aims to develop new anti-TB drugs that can effectively kill drug-resistant strains of the bacteria. The approach involves testing various compounds to see how well they inhibit PptT and subsequently affect the growth of TB in laboratory settings. If successful, this could lead to more effective treatments for patients suffering from TB.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with tuberculosis, especially those who have not responded to standard treatments.
Not a fit: Patients with non-infectious diseases or those without a tuberculosis diagnosis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new treatment options for patients with tuberculosis, particularly those with drug-resistant forms of the disease.
How similar studies have performed: Other research has shown promise in targeting similar mechanisms for drug development against tuberculosis, indicating a potential for success in this approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Aube, Jeffrey — Univ of North Carolina Chapel Hill
- Study coordinator: Aube, Jeffrey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.